Navigation Links
'Emerging contaminants of concern' detected throughout Narragansett Bay watershed
Date:9/21/2011

URI researcher: 'Emerging contaminants of concern' detected throughout Narragansett Bay watershed

NARRAGANSETT, R.I. September 21, 2011 A group of hazardous chemical compounds that are common in industrial processes and personal care products but which are not typically monitored by the Environmental Protection Agency have been detected throughout the Narragansett Bay watershed, according to a URI researcher.

Rainer Lohmann, associate professor of chemical oceanography, and graduate student Victoria Sacks, with the help of 40 volunteers, tested for the presence of the chemicals in 27 locations. The compounds were found at every site.

"Being exposed to these compounds is the hidden cost of our lifestyle," said Lohmann. "It's frustrating that as we ban the use of some chemical compounds, industry is adding new ones that we don't know are any better."

Lohmann said the good news is that the chemicals were detected at extremely low levels.

"By themselves, none of these results makes me think that we shouldn't be swimming in the bay or eating fish caught there," he said. "But we only tested for three compounds that might be of concern, and we know there are hundreds more out there. The totality of all those compounds together is what may be worrisome."

The three compounds the researchers measured, which scientists refer to as "emerging contaminants of concern," are: triclosans, antibacterial agents found in many personal care products and which have been identified as posing risks to humans and the environment; alkylphenols, widely used as detergents and known to disrupt the reproductive system; and PBDEs, industrial products used as flame retardants on a wide variety of consumer products. PBDEs have been banned because they cause long-term adverse effects in humans and wildlife.

PBDEs, methyltriclosan and triclosan were found in highest concentrations in the Blackstone River, Woonasquatucket River and i
'/>"/>

Contact: Todd McLeish
tmcleish@uri.edu
40-187-478-982
University of Rhode Island
Source:Eurekalert

Page: 1 2

Related biology news :

1. Systech International and Zetes Partner to Meet Europes Emerging Pharmaceutical Regulatory Requirements
2. Emerging research in brain connectivity reveals new understanding of neurological disorders
3. UMass med school professor wins coveted emerging-investigator award
4. BUSM faculty author commentary on the global challenges of emerging viral infections
5. ASM Biodefense and Emerging Diseases Research Meeting
6. New study examines immunity in emerging species of a major mosquito carrer of malaria
7. Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies
8. 2010 International Conference on Emerging Infectious Diseases
9. National Geographic names University of Chicago researcher an Emerging Explorer for 2010
10. AIBS names emerging public policy leaders
11. Emerging science, tech advances highlight new NIH Common Fund programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... -- The routine use of a molecular testing ... of performing the correct initial surgery for patients ... the University of Pittsburgh Cancer Institute (UPCI), partner ... UPMC/UPCI Multidisciplinary Thyroid Center and other diagnostic testing ... correct initial surgery by 30 percent, according to ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... disturbance has different effects on different species of ... Universities of Bristol and Exeter which tested fish ... to a flying seagull predator model when exposed ... in European minnows. , Lead author Dr ... said: "Noise levels in many aquatic environments have ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... , During heavy rain, the lid of Nepenthes ... that seek shelter on its underside directly into the ... published today, Wednesday 13 June, in the journal ... insects as a source of nutrients, enabling them to ...
... unfathomable only a few years ago are reality today ... the acquisition of next-generation sequencing technology on the Texas ... of the service. "As we move into the ... in history," said Dr. Charles Johnson, director of the ...
... wide range of diseases and uncover fundamental processes that lead ... for biomedical science. A number of hurdles, both scientific and ... of using these special cells to treat heart disease, diabetes, ... June 13 in Nature , scientists at the Salk ...
Cached Biology News:Pitcher plant uses rain drops to capture prey 2Next-generation sequencing technology opens doors to discoveries 2'Magical state' of embryonic stem cells may help overcome hurdles to therapeutics 2'Magical state' of embryonic stem cells may help overcome hurdles to therapeutics 3
(Date:7/24/2014)... leader Yung-Eun Sung has announced that they have ... graphenes which can be applied as high performance ... Sung is both a group leader at the ... Science* (IBS) and a professor at the Seoul ... with regards to the development of relative simplicity, ...
(Date:7/24/2014)... Although most natural and synthetic processes prefer to ... potential or energyit is within the realm of ... experience constant changes in energy and phases, such ... These conditions allow humans to regulate their body ... rumble with seismic activity. , But even ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)... Three companies from the angelMD network ... C Competition. Out of 700 competition entrants, Chiron Health, ... semi-final round. In this round twenty teams are invited ... with mentoring from thought-leaders and medical entrepreneurs from all ... angelMD commitment to the Livestrong vision around the Big ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Getting More Life out of Lithium-ion Batteries 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... , MURRIETA, Calif., Aug. 27 Despite ... of its US operations. Copan Diagnostics, Inc. is undertaking a ... and additional medical device manufacturing operations to its facility in ... molding machinery and filling and packing equipment to expand Copan,s ...
... , GAITHERSBURG, Md., Aug. 27 GenVec, ... into a purchase agreement with a single institutional investor for the sale ... shares of its common stock. The shares of common stock and ... stock and 0.50 warrants to purchase one share of common stock at ...
... Elbit Imaging Ltd.,("EMI" or the "Company") (NASDAQ: EMITF ... the Page" of Series B Notes of the Company,that the interest ... August 21, 2009 and ending on February 20, 2010 is 1.723125%. ... The Activities of Elbit Imaging Ltd. are divided ...
Cached Biology Technology:Copan Announces Multimillion Expansion for US Pipet Manufacturing Operations 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 3Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes 2Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes 3
BOND ELUT MATRIX-C18, 25 mg ...
Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Human Legumain Affinity Purified Polyclonal Ab...
Biology Products: